Risk scores versus natriuretic peptides for identifying prevalent stage B heart failure

• Published in: The American heart journal Vol. 161; no. 5; pp. 923 - 930.e2
• Main Authors: Gupta, Sachin, Rohatgi, Anand, Ayers, Colby R., Patel, Parag C., Matulevicius, Susan A., Peshock, Ronald M., Markham, David W., de Lemos, James A., Berry, Jarett D., Drazner, Mark H.
• Format: Journal Article
• Language: English
• Published: New York, NY Mosby, Inc 01.05.2011; Mosby; Elsevier Limited
• Subjects: Adult; Aged; Biological and medical sciences; Cardiology; Cardiology. Vascular system; Cardiovascular; Cardiovascular disease; Drug therapy; Female; Follow-Up Studies; Heart; Heart attacks; Heart Failure - blood; Heart Failure - epidemiology; Heart failure, cardiogenic pulmonary edema, cardiac enlargement; Humans; Male; Medical sciences; Middle Aged; Natriuretic Peptides - blood; Prevalence; Prospective Studies; Risk Assessment - methods; Risk Factors; Severity of Illness Index; United States - epidemiology; Womens health; United States; Heart failure; Prevalence; Peptides; Heart disease; Risk factor; Cardiovascular disease; Risk; Circulatory system; Cardiology; Epidemiology; Comparative study

Identifying asymptomatic individuals with American Heart Association/American College of Cardiology stage B heart failure (HF) in the population is an important step to prevent the development of symptomatic HF. The comparative utility of 2 screening strategies (biomarkers vs risk scores) in identif...